Serum androgen profile of elite athletes
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgag196 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von David J Handelsman und 1 weiteren Autor:innen. Beteiligte Einrichtung: ANZAC Research Institute, University of Sydney, Sydney, NSW 2139, Australia. Hauptthemen laut MEDLINE: Athletes, Androgens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The binary sex classification protects elite female athletes from the male physical advantages arising from puberty; however, mutations causing XY disorders of sex development (DSD) challenge the binary sex classification. Hormonal features of the most frequent XY DSDs in sports, androgen insensitivity syndrome (AIS) and 5α-reductase type 2 deficiency (5ARD) are not well described.
Aims
To define serum androgen profiles in elite athletics (track and field) events Methods Serum samples from elite athletes (n = 1689; male 889, female 800; n = 5516 samples, median 3 per person) were analyzed by liquid chromatography–mass spectrometry (LCMS) for serum testosterone (T), dihydrotestosterone (DHT), and androstenedione in 19 World Anti-Doping Agency (WADA)-accredited laboratories. Serum steroids and ratios were analyzed by linear mixed model for repeated measures with adjustment for multiple comparisons and imputation for left-censored (dihydrotestosterone [DHT]) data. Among females, XY DSD identified by adult male serum T concentrations, had clinical diagnosis of 5ARD, AIS, or unclassified (UNCL).
Results
XY DSD comprised 12 individuals with 5ARD with 2 with AIS (1 complete). Excluding pregnancy or androgen doping samples, men had higher serum T (n = 2671, 19.7 ± 0.1 nmol/L) and T/DHT ratio (n = 1903, 14.4 ± 0.2) than women (n = 2793, 1.1 ± 0.1 nmol/L; n = 1809, 3.7 ± 0.12, respectively) with XY DSD featuring male-like results (n = 52, 28.9 ± 0.8 nmol/L; n = 39; 32.0 ± 1.3).
Conclusion
The prevalence of XY DSD in elite female athletes greatly exceeds that of the community with a high proportion of androgen-sensitive 5ARD. Serum T/DHT ratio by LCMS to characterize 5ARD can be extended to elite athletes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ANZAC Research Institute, University of Sydney, Sydney, NSW 2139, Australia.
- Andrology Department, Concord Hospital, Sydney, NSW 2139, Australia.
- Health and Science Department, World Athletics, 6-8 quai Antoine 1er, 98000 Monaco, Monaco.
- LAMHESS, Université Côte D'Azur, Nice, France.
ORCID-Profile: David J Handelsman
Zitieren
APA
Handelsman, D. J., & Bermon, S. (2026). Serum androgen profile of elite athletes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag196
Vancouver
Handelsman DJ, Bermon S. Serum androgen profile of elite athletes. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag196
BibTeX
@article{Handelsman2026,
author = {Handelsman, David J and Bermon, Stephane},
title = {Serum androgen profile of elite athletes},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag196}
}
EUVIMED